山外山:2025年净利润预计1.4亿元到1.59亿元,业务毛利率提升导致整体盈利能力加强

Core Viewpoint - The company, Shanwaishan, expects to achieve a net profit attributable to shareholders of 140 million to 159 million yuan in 2025, representing a year-on-year increase of 98% to 125% [1] - The net profit after deducting non-recurring gains and losses is projected to be 134 million to 154 million yuan, reflecting a year-on-year increase of 135% to 170% [1] Summary by Categories Financial Performance - The anticipated increase in net profit is primarily driven by the company's position as a leading domestic manufacturer of blood purification equipment, leveraging technological advantages and brand effects to boost sales revenue [1] - Significant growth in sales revenue from self-produced blood purification consumables has contributed to the overall financial performance [1] - The increase in production and sales volume has led to a decrease in fixed costs per unit for self-produced consumables, resulting in improved gross margins and overall profitability [1]

SWS Medical-山外山:2025年净利润预计1.4亿元到1.59亿元,业务毛利率提升导致整体盈利能力加强 - Reportify